Why the study?
Does percutaneous edge-to-edge repair using the MitraClip system improve symptoms in a patient with congenitally corrected transposition of the great arteries and severe tricuspid regurgitation?
Does percutaneous edge-to-edge repair using the MitraClip system improve symptoms in a patient with congenitally corrected transposition of the great arteries and severe tricuspid regurgitation?
Percutaneous edge-to-edge repair using the MitraClip system may be a feasible and effective treatment for severe tricuspid regurgitation in patients with congenitally corrected transposition of the great arteries.
Supports short-term symptom relief with MitraClip in ccTGA and severe TR; hypothesis-generating and should not yet change practice.
A 62-year-old woman presented with shortness of breath and NYHA III. Severe heart failure was due to reduced systolic function. The woman reported of lung edema at two times. Computed tomography scan and magnetic resonance imaging showed a congenitally corrected transposition of the great arteries (CC-TGA). Echocardiographic findings revealed a high grade tricuspid regurgitation. For treatment of the tricuspid regurgitation, we used a percutaneous approach. The Evalve MitraClip(®) system has demonstrated feasibility and safety in the treatment of mitral regurgitation. Three months after successful tricuspid valve clipping, the patient is fine and NYHA score is reduced to grade I.
No takes yet. Share an insight, caveat, or question.
Franzen et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: